United States · Funded startup

Who invested in NeuroGenetic Pharmaceuticals

7 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$14Mraised across 7 rounds since 2002, from 7 sources

$10MSeries B$1.1MVenture$250KDebt$100KVenture$50KDebt$2.5MGrant
Latest round
Grant, $2.5MNov 2015
Biggest round
$10MSeries B · Nov 2002
Step-upi
50×
Investors
6
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2002200420062008201020122014
$10MSeries B$1.1MVenture?Round$250KDebt$100KVenture$50KDebt$2.5MGrant
First round
Series B, $10M
Nov 2002
Biggest round
$10M
Series B · Nov 2002
Usual gap between rounds
15 months
the median of 6

The rounds

  1. Nov 2015
    Grant$2.5M

    No investor was named in the report.

    From a historical funding record

  2. Mar 2015
    Debt$50K

    No investor was named in the report.

    From a historical funding recordSEC filing: $50K sold, first sale Feb 2015

  3. Jan 2014
    Venture$100K

    No investor was named in the report.

    From a historical funding recordSEC filing: $100K sold, first sale Dec 2013

  4. Oct 2012
    Debt$250K

    No investor was named in the report.

    Reported by sec.govSEC filing: $250K sold, first sale Sept 2012

  5. Jan 2012
    RoundAmount undisclosed1 new

    Reported by finsmes.comSEC filing: $500K sold, first sale Dec 2011

  6. Jul 2010
    Venture$1.1M

    No investor was named in the report.

    From a historical funding recordSEC filing: $1.1M sold, first sale Jun 2010

  7. Nov 2002

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2002Venture2010Round2012Debt2012Venture2014Debt2015Grant2015Novartis Venture FundAlta PartnersAdvent InternationalS.R. One , LimitedAbbott Biotech VenturesEisai

Everyone who backed them

Novartis Venture FundCorporate VC1round
Alta PartnersVC firm1round
Advent InternationalPrivate equity1round
S.R. One , LimitedGrowth equity1round
EisaiCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about NeuroGenetic Pharmaceuticals

Who invested in NeuroGenetic Pharmaceuticals?

NeuroGenetic Pharmaceuticals's investors include Novartis Venture Fund, Alta Partners, Advent International, S.R. One , Limited and Abbott Biotech Ventures, and 1 more on record.

How much has NeuroGenetic Pharmaceuticals raised?

NeuroGenetic Pharmaceuticals has raised $14M across 7 rounds since 2002. One round did not disclose an amount, so the total is a floor.

When did NeuroGenetic Pharmaceuticals last raise?

NeuroGenetic Pharmaceuticals's most recent round was a Grant of $2.5M in Nov 2015.

What was NeuroGenetic Pharmaceuticals's biggest round?

NeuroGenetic Pharmaceuticals's largest round on record is $10M (Series B), in Nov 2002.

Who backed NeuroGenetic Pharmaceuticals first?

NeuroGenetic Pharmaceuticals's first round on record, in Nov 2002, was backed by Novartis Venture Fund, Alta Partners and Advent International and 2 others.

What stage is NeuroGenetic Pharmaceuticals at?

NeuroGenetic Pharmaceuticals's latest named round is a Grant, in Nov 2015.

Where is NeuroGenetic Pharmaceuticals based?

NeuroGenetic Pharmaceuticals is based in the United States.

Companies like NeuroGenetic Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.